Immunosuppressive effects of macrophage lysis.
D000818:Animals; D002351:Carrageenan / Q000008:administration & dosage / Q000494:pharmacology; D007108:Immune Tolerance; D007165:Immunosuppression Therapy; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008247:Lysosomes / Q000201:enzymology; D008264:Macrophages / Q000187:drug effects / Q000276:immunology*; D051379:Mice; D010587:Phagocytosis; D012822:Silicon Dioxide / Q000008:administration & dosage / Q000494:pharmacology; D016038:Skin Transplantation; D013997:Time Factors; D014022:Tissue Survival; D014184:Transplantation, Homologous
D012822:Silicon Dioxide; D002351:Carrageenan